Chandra Bhagat Pharma share news and announcements
BSE: 542934Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹40.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,869th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 25 May 2026
- 10.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 25 May 2026
- 9.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.50
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,000
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Chandra Bhagat Pharma half-yearly results
The board met on 25 May 2026 to consider audited results
Notice filed 19 May 2026
Chandra Bhagat Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Chandra Bhagat Pharma financials, year by year
Annual reports7
- Annual report, year to Mar 2026 (opens in a new tab)6 Aug 2026
- Annual report, year to Mar 2025 (opens in a new tab)6 Sep 2025
- Annual report, year to Mar 2024 (opens in a new tab)7 Sep 2024
- Annual report, year to Mar 2023 (opens in a new tab)5 Sep 2023
- Annual report, year to Mar 2022 (opens in a new tab)6 Sep 2022
2 earlier reports
Chandra Bhagat Pharma share news and announcements
141 announcements, routine notices left out, newest first. Page 1 of 3.
Oct 2026
22 Oct · Announcement under Regulation 30 (LODR)-Allotment
21 Oct · Certificate For Non-Applicability Of Corporate Governance For The Quarter Ended 30Th September, 2026.
13 Oct · Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 For Receipt Of BSE IP Approval
Sep 2026
Aug 2026
5 Aug · Board meeting
Jul 2026
30 Jul · Board meeting
Meeting on 5 Aug 2026: increase in authorised capital and preferential issue of shares21 Jul · Non-Applicability Of CG Report
May 2026
19 May · Board meeting
Meeting on 25 May 2026: audited results
Apr 2026
21 Apr · Certificate For NON-Applicability Of Corporate Governance As On 31 March 2026.
1 Apr · Disclosure Under Regulation 30.
Jan 2026
21 Jan · Non Applicability Of Corporate Governance Report Certificate.
Nov 2025
7 Nov · Board meeting
Meeting on 13 Nov 2025: half yearly results
Oct 2025
20 Oct · Disclosure
Sep 2025
30 Sep · Meeting
6 Sep · Board meeting
May 2025
29 May · Management
29 May · Result For The Financial Year March 31, 2025.
26 May · Board meeting
Meeting on 29 May 2025: audited results
Apr 2025
21 Apr · General-Updates
Jan 2025
Nov 2024
13 Nov · Result For The Half Year Ended As On September 30, 2024.
13 Nov · Board meeting
7 Nov · Board meeting
Meeting on 13 Nov 2024: half yearly results
Oct 2024
2 Oct · Voting Result
Sep 2024
Jul 2024
19 Jul · Non-Applicability Of CGR Report Certificate.
May 2024
30 May · Result As On March 31, 2024
30 May · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 5 Oct 2026Board or managers changeddown 5.00%−3.8 pts vs Nifty 500market median 0.0% · five sessions −15.4% (−14.7 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
- 5 Jan 2022Board or managers changeddown 0.76%−1.3 pts vs Nifty 500market median 0.0% · five sessions −0.6% (−3.2 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)